Northwest Biotherapeutics, Inc.
NWBOW
NWBOW was delisted on the 16th of December, 2016.
1 hedge funds and large institutions have $180K invested in Northwest Biotherapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
33% more capital invested
Capital invested by funds: $135K → $180K (+$45K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Allianz Asset Management
Munich,
Germany
| $180K | – | – | – |
|
NWBOW Hedge Fund Activity: Q3 2013 in Review
1 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. (NWBOW) for Q3 2013, worth a combined $180K — up 33% from $135K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NWBOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
- 1 institutional investor held Northwest Biotherapeutics, Inc. (NWBOW) as of Q3 2013, down from 2 in Q2 2013.
- Funds reported $180K of Northwest Biotherapeutics, Inc. stock for Q3 2013, up 33% quarter-over-quarter.
- 0 funds opened new Northwest Biotherapeutics, Inc. positions in Q3 2013 and 1 closed out, a net change of -1 holder.
Based on aggregated 13F filings for Q3 2013.